688687 logo

Beijing Kawin Technology Share-Holding Co., Ltd. Stock Price

SHSE:688687 Community·CN¥3.3b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

688687 Share Price Performance

CN¥19.76
-7.23 (-26.79%)
CN¥19.76
-7.23 (-26.79%)
Price CN¥19.76

688687 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Undervalued with excellent balance sheet.

3 Risks
3 Rewards

Beijing Kawin Technology Share-Holding Co., Ltd. Key Details

CN¥1.3b

Revenue

CN¥252.1m

Cost of Revenue

CN¥1.0b

Gross Profit

CN¥1.0b

Other Expenses

CN¥11.1m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
0.066
80.55%
0.85%
27.7%
View Full Analysis

About 688687

Founded
2008
Employees
600
CEO
Desheng Zhou
WebsiteView website
www.kawin.com.cn

Beijing Kawin Technology Share-Holding Co., Ltd., a biopharmaceutical company, provides treatment solutions for viral and immune diseases in China and internationally. The company offers recombinant human interferon alfa-2b injection; interferon alfa-2b vaginal effervescent tablets; coblopasvir hydrocholoride capsules; sofosbuvir tablets; peginterferon alfacon-2 injection; and compound glycyrrhizin tablets, capsules, and injections; and pirfenidone tablets for mild to moderate idiopathic pulmonary fibrosis. It is also involved in contract manufacture organization/contract development and manufacturing organization; technology and biotechnology development; technical consulting; biotechnology consulting; science and technology promotion and application; and wholesale of medical supplies. Beijing Kawin Technology Share-Holding Co., Ltd. was incorporated in 2008 and is based in Beijing, China.

Recent 688687 News & Updates

Recent updates

No updates